Article Hero

Qualtrics, and Ortho ready to become public companies

1611834996.png
Miguel A. Rodriguez
Miguel A. Rodriguez
29 January 2021
Two IPOs are hitting the market today: Qualtrics, and Ortho Clinical Diagnostics

Full day ahead for the markets, as two companies are ready to become public. IPOs have once again taken center stage, and increased investor appetite has seen the Renaissance IPO ETF skyrocket 106.76% between Jan 2020 and Jan 2021.

Qualtrics

The Utah-based software company is prepared to go public, by offering 50.4 million shares which prices range from $27 to $29 apiece. If everything goes smoothly, Qualtrics will reach a market valuation of nearly $15 billion, significantly higher than its first IPO in November 2018 – when it had a market cap of $4.3 billion.

The IPO proceeds will be used to pay the $1.76 billion debt owed to SAP America – the company which in 2018 bought it for $8 billion.

Qualtrics will be available for trading on the Nasdaq under the ticker XM, and as underwriters will be Morgan Stanley and JP Morgan.

 

Ortho Clinical Diagnostics

The global leader of in vitro diagnostics and a pioneer in innovative laboratory testing and blood-typing solutions will go public today under the symbol OCDX on the Nasdaq Global Select Market.

Ortho will make available for purchase 76 million shares priced at $17 each, with the gross proceeds expected to reach $1,292 million. The net proceeds from the IPO will be used to repay various borrowings made under its dollar term loan facility, and for general corporate purposes, along with working capital.

As underwriters, the clinic named JP Morgan, BofA Securities, and Goldman Sachs, among others.

Stay updated with CAPEX.com!

 

Sources: bloomberg.com, prnewswire.com, investors.com

disclaimers_articles

article_share_title

article_rating_title

awful
ok
great
awesome

read_more

Miguel A. Rodriguez
Miguel A. Rodriguez
financial_writer

Miguel worked for major financial institutions such as Banco Santander, and Banco Central-Hispano. He is a published author of currency trading books.